Massachusetts Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $64.3M | Buy |
1,050,815
+282,775
| +37% | +$16.5M | 0.02% | 436 |
|
|
2025
Q4 | $41.4M | Buy |
768,040
+685,961
| +836% | +$33M | 0.01% | 508 |
|
|
2025
Q3 | $3.7M | Buy |
82,079
+3,184
| +4% | +$149K | ﹤0.01% | 728 |
|
|
2025
Q2 | $3.65M | Buy |
78,895
+41,212
| +109% | +$2.02M | ﹤0.01% | 730 |
|
|
2025
Q1 | $2.3M | Buy |
+37,683
| New | +$2.2M | ﹤0.01% | 744 |
|
|
2023
Q3 | – | Sell |
-3,515
| Closed | -$225K | – | 842 |
|
|
2023
Q2 | $225K | Sell |
3,515
-14,860
| -81% | -$996K | ﹤0.01% | 810 |
|
|
2023
Q1 | $1.27M | Buy |
18,375
+1,591
| +9% | +$112K | ﹤0.01% | 743 |
|
|
2022
Q4 | $1.21M | Buy |
16,784
+12,661
| +307% | +$955K | ﹤0.01% | 761 |
|
|
2022
Q3 | $293K | Sell |
4,123
-305
| -7% | -$22.1K | ﹤0.01% | 834 |
|
|
2022
Q2 | $341K | Buy |
4,428
+392
| +10% | +$29.9K | ﹤0.01% | 826 |
|
|
2022
Q1 | $295K | Sell |
4,036
-38,527
| -91% | -$2.59M | ﹤0.01% | 845 |
|
|
2021
Q4 | $2.65M | Buy |
42,563
+403
| +1% | +$23.6K | ﹤0.01% | 748 |
|
|
2021
Q3 | $2.5M | Buy |
42,160
+35,583
| +541% | +$2.34M | ﹤0.01% | 760 |
|
|
2021
Q2 | $439K | Sell |
6,577
-7,288
| -53% | -$475K | ﹤0.01% | 881 |
|
|
2021
Q1 | $875K | Buy |
+13,865
| New | +$863K | ﹤0.01% | 850 |
|
|
2020
Q4 | – | Sell |
-409,953
| Closed | -$24.7M | – | 885 |
|
|
2020
Q3 | $24.7M | Sell |
409,953
-192,689
| -32% | -$11.6M | 0.01% | 543 |
|
|
2020
Q2 | $35.4M | Sell |
602,642
-260,199
| -30% | -$15.6M | 0.01% | 466 |
|
|
2020
Q1 | $48.1M | Sell |
862,841
-639,046
| -43% | -$39.1M | 0.02% | 380 |
|
|
2019
Q4 | $96.4M | Buy |
1,501,887
+92,854
| +7% | +$5.32M | 0.04% | 334 |
|
|
2019
Q3 | $71.5M | Sell |
1,409,033
-924,451
| -40% | -$43.4M | 0.03% | 367 |
|
|
2019
Q2 | $106M | Sell |
2,333,484
-2,658,488
| -53% | -$124M | 0.04% | 298 |
|
|
2019
Q1 | $238M | Sell |
4,991,972
-4,828,062
| -49% | -$241M | 0.1% | 179 |
|
|
2018
Q4 | $510M | Buy |
9,820,034
+359,886
| +4% | +$19.3M | 0.25% | 107 |
|
|
2018
Q3 | $587M | Buy |
9,460,148
+2,903,920
| +44% | +$172M | 0.24% | 109 |
|
|
2018
Q2 | $363M | Sell |
6,556,228
-122,405
| -2% | -$6.61M | 0.16% | 146 |
|
|
2018
Q1 | $422M | Buy |
6,678,633
+468,740
| +8% | +$30.2M | 0.18% | 134 |
|
|
2017
Q4 | $381M | Buy |
6,209,893
+1,081,642
| +21% | +$67.7M | 0.16% | 149 |
|
|
2017
Q3 | $327M | Buy |
5,128,251
+2,682,106
| +110% | +$157M | 0.14% | 156 |
|
|
2017
Q2 | $136M | Buy |
2,446,145
+8,047
| +0.3% | +$438K | 0.06% | 229 |
|
|
2017
Q1 | $133M | Sell |
2,438,098
-903,897
| -27% | -$49.6M | 0.06% | 220 |
|
|
2016
Q4 | $195M | Sell |
3,341,995
-1,647,332
| -33% | -$90.1M | 0.1% | 182 |
|
|
2016
Q3 | $269M | Sell |
4,989,327
-2,836,722
| -36% | -$182M | 0.13% | 158 |
|
|
2016
Q2 | $576M | Sell |
7,826,049
-2,009,227
| -20% | -$142M | 0.29% | 99 |
|
|
2016
Q1 | $628M | Sell |
9,835,276
-2,849,008
| -22% | -$180M | 0.33% | 87 |
|
|
2015
Q4 | $873M | Sell |
12,684,284
-31,237
| -0.2% | -$2.06M | 0.47% | 64 |
|
|
2015
Q3 | $753M | Buy |
12,715,521
+191,225
| +2% | +$12.1M | 0.42% | 72 |
|
|
2015
Q2 | $833M | Sell |
12,524,296
-347,301
| -3% | -$22.9M | 0.42% | 67 |
|
|
2015
Q1 | $830M | Buy |
12,871,597
+144,397
| +1% | +$9.04M | 0.42% | 67 |
|
|
2014
Q4 | $751M | Buy |
12,727,200
+621,931
| +5% | +$35.1M | 0.38% | 75 |
|
|
2014
Q3 | $620M | Buy |
12,105,269
+689,455
| +6% | +$34.4M | 0.33% | 78 |
|
|
2014
Q2 | $554M | Buy |
11,415,814
+1,611,658
| +16% | +$79.4M | 0.29% | 83 |
|
|
2014
Q1 | $509M | Buy |
9,804,156
+71,954
| +0.7% | +$3.83M | 0.28% | 86 |
|
|
2013
Q4 | $517M | Buy |
9,732,202
+349,556
| +4% | +$17.8M | 0.29% | 84 |
|
|
2013
Q3 | $434M | Buy |
9,382,646
+3,184,270
| +51% | +$140M | 0.27% | 87 |
|
|
2013
Q2 | $277M | Buy |
+6,198,376
| New | +$269M | 0.19% | 116 |
|
Other funds holding BMY
VCM
VPM
Massachusetts Financial Services's BMY Position: Q1 2026 in Review
Massachusetts Financial Services increased its Bristol-Myers Squibb (BMY) stake by 37% in Q1 2026, buying an estimated $16.5M and bringing the position to 1,050,815 shares worth $64.3M. The position accounts for 0.02% of the portfolio, ranked #436.
Massachusetts Financial Services first reported a position in BMY in Q2 2013 and has held it in 45 quarters since. The position peaked at $873M in Q4 2015. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Massachusetts Financial Services held 1,050,815 shares of Bristol-Myers Squibb worth $64.3M as of Q1 2026.
- Massachusetts Financial Services bought 282,775 Bristol-Myers Squibb shares in Q1 2026, an estimated $16.5M.
- Bristol-Myers Squibb made up 0.02% of Massachusetts Financial Services's portfolio in Q1 2026, its #436 holding.
- Massachusetts Financial Services first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 45 quarters since.
- Massachusetts Financial Services's Bristol-Myers Squibb position peaked at $873M in Q4 2015.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.